GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Antibody Patient Onset (days) ▲ Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU)
IgA
Patient 3
-180
mild
3775
IgA
Patient 3
-180
mild
320
IgA
Patient 3
-180
mild
275
IgA
Patient 3
-180
mild
350
IgA
Patient 3
-180
mild
2520
IgA
Patient 3
-180
mild
1428
IgA
Patient 3
-180
mild
251
IgA
Patient 3
-180
mild
232
IgA
Patient 3
-180
mild
264
IgA
Patient 3
-180
mild
274
Displaying entries 41 - 50 of 4050 in total

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01